F
FLNA
Filana Therapeutics
0.6355
-0.0186-2.84%After Hours: 0.6402 +0.0047 +0.74%19:49 10/23 EDT
OPEN/PREV CLOSE0.6440/0.6541
TODAY RANGE0.6156-0.6533
VOL313.55K
MARKET CAP30.70M
52 WEEK RANGE0.6156-4.690
AVG VOL (3M)2.02M
% TURNOVER0.64%
TURNOVER--
P/E (TTM)-0.7260
% RANGE5.76%
EPS(TTM)-0.8753
P/E(FORWARD)-0.7101
P/B0.4826
BVPS1.317
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP30.07M
SHARES OUTSTANDING48.31M
NEXT EARNINGS11/10-11/16
FREE FLOAT47.32M
LOT SIZE1
EX-DATE12/21/2023
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
Appeals Court Vacates Class Certification in Filana Case
TipRanks·10/03 13:00
Hewlett Packard, Everpure, Filana, Ciena & Marriott Insider Shake‑Up
TipRanks·10/02 02:02
Filana Therapeutics CEO Makes Bold Insider Move That Could Signal Big Upside
NASDAQ·10/01 17:49
Thursday 10/1 Insider Buying Report: KBDC, FLNA
Benzinga·10/01 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·09/30 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga·09/22 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·09/22 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·09/22 16:47
Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
TipRanks·09/22 14:05
Filana can proceed with study as hold lifted, says Lucid Capital
TipRanks·09/22 12:51
Filana Therapeutics advances simufilam in TSC epilepsy trial
TipRanks·09/22 12:20
Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam
Same Industry